Novel Coronavirus (SARS-CoV-2/COVID-19)
U.S. health care providers may no longer order the monoclonal antibodies bamlanivimab and etesevimab until further notice due to rising prevalence of the SARS-CoV-2 P.1 and B.1.351 variants, which are not susceptible to the combination therapy, the Department of Health and Human Services’ Office of…
The Infectious Diseases Clinical Research Consortium has begun enrolling up to 1,000 pregnant and postpartum individuals who have or will receive COVID-19 vaccine in a study to assess vaccine safety, immune response and transfer of antibodies to their infants, the National Institutes of Health…
Photo Credit: Hawaii Pacific Health
An estimated 16.8 million U.S. adults had undiagnosed COVID-19 by July 2020, representing 4.6% of U.S. adults and 4.8 undiagnosed infections for every diagnosed case, according to a National Institutes of Health study published by the journal Science Translational Medicine. NIH’s SARS-CoV-2…
AHA urged the Department of Health and Human Services to allow all health care providers to use their COVID-19 Provider Relief Fund payments until June 30, 2022, or the end of the COVID-19 public health emergency, whichever is later.
Sutter Health and community partners are reaching out to areas in Northern California with high rates of COVID-19 cases and with residents who are hesitant to get the vaccine.
Tampa General Hospital joined one of the first COVID-19 vaccine pilot programs and also is the first hospital in Florida to offer monoclonal antibody treatment.
For many Arkansans getting the COVID-19 vaccine at a Baptist Health clinic, the decision was made after a little reflection.
Vanderbilt Health extends its vaccine partnerships to include Nashville royalty and businesses.
The Department of Health and Human Services announced a $3 billion investment in antiviral treatments for COVID-19, particularly those administered orally. The money will go toward advancing the next stages of COVID-19 treatments, including their discovery, development and manufacturing.